ARTICLE | Clinical News
Once daily ADHD results
October 27, 2000 7:00 AM UTC
Both Shire (LSE:SHP; SHPGY) and Medeva, a subsidiary of Celltech (LSE:CCH, CLL), announced separate results from clinical development of a single daily dose formulation to treat ADHD. SHP said SLI 381...